Savella FDA Approval History
FDA Approved: Yes (First approved January 14, 2009)
Brand name: Savella
Generic name: milnacipran
Company: AbbVie Inc.
Treatment for: Fibromyalgia
Savella (milnacipran) is a selective serotonin and norepinephrine reuptake inhibitor indicated for the management of fibromyalgia.
Development timeline for Savella
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.